The inhibitor had a profound effect on the viability and colony-forming ability of FLT3-ITD/NPM1 and FLT3-ITD+ AML cells but not healthy cells in culture (Figures 6B and S6B). The gene discussed is FLT3; the disease is acute myeloid leukemia.